Theragenics Corporation (TGX) Reports Revenue and Earnings for the Second Quarter and First Half of 2012  
8/9/2012 10:45:02 AM

BUFORD, Ga.--(BUSINESS WIRE)--Theragenics Corporation® (NYSE: TGX), a medical device company serving the surgical products and prostate cancer treatment markets, today announced consolidated financial results for the second quarter ended June 30, 2012.